Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level

Cytometry Part B - Clinical Cytometry

Volumn 80 B, Issue 1, 2011, Pages 22-27

  Scrivo, Rossana ^a   Morrone, Stefania ^a   Spadaro, Antonio ^a   Santoni, Angela ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

cytokines; cytotoxicity; Natural killer cells; spondyloarthitis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ADULT; AGED; CELL DEGRANULATION; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, KIR3DL1; SINGLE-CELL ANALYSIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650806558     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20549     Document Type: Article

References (20)

1. Kirwan SE, Burshtyn DN,. Regulation of natural killer cell activity. Curr Opin Immunol 2007; 19: 46 - 54.
2. French AR, Yokoyama WM,. NK cells and autoimmunity. Arthritis Res Ther 2004; 6: 8 - 14.
3. Spadaro A, Scrivo R, Moretti T, Bernardini G, Riccieri V, Taccari E, Strom R, Valesini G,. Natural killer cells and gamma/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis. Clin Exp Rheumatol 2004; 22: 389 - 394.
4. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, Shin MH, Park JJ, Kim TJ, Lee SS, Yoo DH, Kang HS,. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 1753 - 1763.
5. Khan MA,. Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896 - 907.
6. FitzGerald O, McInnes I,. Spondyloarthropathy: Disease at the crossroads of immunity. Best Pract Res Clin Rheumatol 2006; 5: 949 - 967.
7. Chan AT, Kollnberger SD, Wedderburn LR, Bowness P,. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 2005; 52: 3586 - 3595.
8. Díaz Peña R, Vidal Castiñeira JR, Alonso Arias R, Suarez Alvarez B, Vicario JL, Solana R, Collantes E, López Vázquez A, Martínez Borra J, López Larrea C,. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum 2010; 62: 1000 - 1006.
9. Vilches C, Parham P,. KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002; 20: 217 - 251.
10. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA,. Sensitive and viable identification of antigen specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65 - 78.
11. Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E, Uharek L,. CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 2005; 19: 835 - 840.
12. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle Oñate R, Weber U, Wei J, Sieper J,. The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (Part II): Validation and final selection. Ann Rheum Dis 2009; 68: 777 - 783.
13. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A,. A new approach to defining disease status in ankylosing spondylitis: The bath ankylosing spondylitis disease activity index. J Rheumatol 1994; 21: 2286 - 2291.
14. Sciaky N, Presley J, Smith C, Zaal KJ, Cole N, Moreira JE, Terasaki M, Siggia E, Lippincott Schwartz J,. Golgi tubule traffic and the effects of brefeldin A visualized in living cells. J Cell Biol 1997; 139: 1137 - 1155.
15. Thoen J, Forre O, Waalen K, Pahle J,. Phenotypes and spontaneous cell cytotoxicity of mononuclear cells from patients with seronegative spondyloarthropathies: Ankylosing spondylitis, psoriatic arthropathy and pauciarticular juvenile chronic arthritis: Analysis of mononuclear cells from peripheral blood, synovial fluid and synovial membranes. Clin Rheumatol 1988; 7: 95 - 106.
16. Azuz Lieberman N, Markel G, Mizrahi S, Gazit R, Hanna J, Achdout H, Gruda R, Katz G, Arnon TI, Battat S, Zamir E, Adawi M, Mader R, Mandelboim O,. The involvement of NK cells in ankylosing spondylitis. Int Immunol 2005; 17: 837 - 845.
17. Bryceson YT, March ME, Ljunggren HG, Long EO,. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006; 214: 73 - 91.
18. Peruzzi M, Parker KC, Long EO, Malnati MS,. Peptide sequence requirements for the recognition of HLA B*2705 by specific natural killer cells. J Immunol 1996; 157: 3350 - 3356.
19. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, McMichael A, Bowness P,. Interaction of HLA B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007; 37: 1313 - 1322.
20. Gardiner CM,. Killer cell immunoglobulin like receptors on NK cells: The how, where and why. Int J Immunogenet 2008; 35: 1 - 8.